Fierce Healthcare

FDA approves Roche's Actemra for treating severe cases of COVID-19

Based partly on results of clinical trials for patients from underrepresented racial and ethnic groups, the Food and Drug Administration (FDA) yesterday approved the use of Actemra for hospitalized ...
Nasdaq

FDA Okays Roche's Actemra For Treatment Of COVID-19 In Hospitalized Adults

(RTTNews) - The U.S. Food and Drug Administration has approved Roche's (RHHBY) Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients who are receiving ...
Forbes

New Monoclonal Antibody Fully Approved For The Treatment Of Covid-19

The Food and Drug Administration has approved an early gift for those suffering from Covid-19 this holiday season. Tocilizumab, branded Actemra by pharmaceutical company Genentech, is a monoclonal ...
Business Wire

FDA Approves the ACTPen for Genentech’s Actemra, a Single-Dose, Prefilled Autoinjector for the Treatment of Rheumatoid Arthritis, Giant Cell Arteritis and Two Forms of ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved ACTPen™ ...
Rheumatology Advisor

Subcutaneous TCZ Shows Higher Long-Term Remission in GCA-Associated Aortitis

Treatment with SC vs IV tocilizumab led to higher long-term remission rates in GCA-associated aortitis, though imaging and glucocorticoid-sparing outcomes were similar.